![logo](/logos/002412.SZ.webp)
Hunan Hansen Pharmaceutical Co., Ltd.
SZSE:002412.SZ
6.55 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 936.622 | 916.062 | 891.835 | 741.237 | 887.491 | 921.95 | 829.938 | 798.467 | 781.128 | 737.425 | 584.932 | 489.461 | 400.786 | 343.415 | 283.211 | 235.689 | 166.939 | 126.747 |
Cost of Revenue
| 272.546 | 255.9 | 245.857 | 220.124 | 232.402 | 236.736 | 224.991 | 230.315 | 225.917 | 212.041 | 151.769 | 122.622 | 96.152 | 80.659 | 67.288 | 57.771 | 44.337 | 36.958 |
Gross Profit
| 664.076 | 660.162 | 645.978 | 521.113 | 655.089 | 685.214 | 604.947 | 568.152 | 555.211 | 525.384 | 433.164 | 366.839 | 304.634 | 262.756 | 215.923 | 177.918 | 122.601 | 89.789 |
Gross Profit Ratio
| 0.709 | 0.721 | 0.724 | 0.703 | 0.738 | 0.743 | 0.729 | 0.712 | 0.711 | 0.712 | 0.741 | 0.749 | 0.76 | 0.765 | 0.762 | 0.755 | 0.734 | 0.708 |
Reseach & Development Expenses
| 42.38 | 47.9 | 39.45 | 31.227 | 33.451 | 36.443 | 50.783 | 47.85 | 52.414 | 27.225 | 20.042 | 7.368 | 4.491 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 23.592 | 18.244 | 14.497 | -24.591 | -30.828 | -32.308 | -55.39 | -51.412 | -49.902 | 14.938 | 23.087 | 13.001 | 8.591 | 33.681 | 19.983 | 19.906 | 13.107 | 13.653 |
Selling & Marketing Expenses
| 394.683 | 396.035 | 401.257 | 334.014 | 362.652 | 428.846 | 382.585 | 380.895 | 354.91 | 308.986 | 244.89 | 244.808 | 217.39 | 164.813 | 129.303 | 99.637 | 59.657 | 47.732 |
SG&A
| 451.773 | 414.279 | 415.753 | 309.423 | 331.824 | 396.538 | 327.195 | 329.483 | 305.008 | 323.923 | 267.977 | 257.809 | 225.981 | 198.494 | 149.287 | 119.544 | 72.765 | 61.384 |
Other Expenses
| -0.082 | 56.995 | 60.866 | 83.222 | 94.013 | -0.345 | -3.455 | 4.553 | 3.154 | 1.636 | 1.984 | -13.788 | -13.216 | 6.267 | 4.178 | 4.723 | 18.249 | 0.373 |
Operating Expenses
| 494.235 | 519.173 | 516.069 | 423.872 | 459.289 | 534.712 | 473.835 | 472.646 | 447.297 | 393.909 | 315.685 | 287.892 | 249.765 | 204.029 | 153.66 | 123.084 | 75.093 | 63.063 |
Operating Income
| 169.841 | 188.791 | 150.272 | 117.87 | 184.955 | 159.461 | 120.032 | 84.404 | 105.965 | 129.946 | 129.081 | 93.878 | 68.593 | 66.822 | 58.538 | 50.447 | 42.132 | 18.689 |
Operating Income Ratio
| 0.181 | 0.206 | 0.168 | 0.159 | 0.208 | 0.173 | 0.145 | 0.106 | 0.136 | 0.176 | 0.221 | 0.192 | 0.171 | 0.195 | 0.207 | 0.214 | 0.252 | 0.147 |
Total Other Income Expenses Net
| -1.576 | -6.938 | -0.371 | -1.559 | 1.148 | 9.386 | -13.275 | -5.299 | 2.922 | 0.921 | 13.432 | 17.348 | 14.676 | 14.363 | -2.687 | -3.743 | 12.873 | -7.664 |
Income Before Tax
| 168.265 | 181.853 | 149.901 | 116.312 | 186.103 | 159.116 | 116.576 | 88.617 | 110.804 | 132.396 | 130.911 | 96.294 | 69.545 | 73.089 | 59.577 | 51.091 | 60.381 | 19.062 |
Income Before Tax Ratio
| 0.18 | 0.199 | 0.168 | 0.157 | 0.21 | 0.173 | 0.14 | 0.111 | 0.142 | 0.18 | 0.224 | 0.197 | 0.174 | 0.213 | 0.21 | 0.217 | 0.362 | 0.15 |
Income Tax Expense
| 21.002 | 14.237 | 15.052 | 11.485 | 26.407 | 18.352 | 18.435 | 14.455 | 17.066 | 20.098 | 19.795 | 14.835 | 10.718 | 11.068 | 10.326 | 8.596 | 20.422 | 6.507 |
Net Income
| 205.015 | 167.616 | 134.849 | 106.146 | 159.696 | 140.764 | 98.142 | 71.492 | 92.656 | 111.8 | 110.833 | 81.459 | 58.827 | 62.021 | 49.25 | 42.495 | 37.874 | 11.248 |
Net Income Ratio
| 0.219 | 0.183 | 0.151 | 0.143 | 0.18 | 0.153 | 0.118 | 0.09 | 0.119 | 0.152 | 0.189 | 0.166 | 0.147 | 0.181 | 0.174 | 0.18 | 0.227 | 0.089 |
EPS
| 0.41 | 0.33 | 0.27 | 0.21 | 0.32 | 0.28 | 0.2 | 0.15 | 0.18 | 0.22 | 0.22 | 0.16 | 0.12 | 0.14 | 0.13 | 0.11 | 0.1 | 0.029 |
EPS Diluted
| 0.41 | 0.33 | 0.27 | 0.21 | 0.32 | 0.28 | 0.2 | 0.15 | 0.18 | 0.22 | 0.22 | 0.16 | 0.12 | 0.14 | 0.13 | 0.11 | 0.1 | 0.029 |
EBITDA
| 221.525 | 277.925 | 248.982 | 200.505 | 292.203 | 223.748 | 178.014 | 138.699 | 155.383 | 173.583 | 141.904 | 107.11 | 81.363 | 82.96 | 71.516 | 62.743 | 52.896 | 28.478 |
EBITDA Ratio
| 0.237 | 0.303 | 0.279 | 0.271 | 0.329 | 0.243 | 0.214 | 0.174 | 0.199 | 0.235 | 0.243 | 0.219 | 0.203 | 0.242 | 0.253 | 0.266 | 0.317 | 0.225 |